India, April 30 -- British lending major HSBC Holdings Plc (HSBA.L,HSBC) reported that its first-quarter profit before tax dropped to $12.65 billion from last year's $12.89 billion. Profit after tax ... Read More
India, April 30 -- Indian shares traded slightly higher on Tuesday, tracking firm cues from global markets. A cautious undertone prevailed as investors awaited the Fed policy meeting and the release ... Read More
India, April 29 -- Paramount Global (PARA, PARAA) reported that its first quarter net loss attributable to the company narrowed to $554 million or $0.87 per share from $1.12 billion or $1.74 per share... Read More
India, April 29 -- Akastor ASA (AKKVF.PK), Monday announced that it has secured a EPCIC-contract by Equinor to enhance the wastewater treatment facilities and minimize environmental footprint of the M... Read More
India, April 29 -- Monday, Tesla, Inc.'s (TSLA) stock saw a significant rise following a noteworthy endorsement of its driver-assist technologies in China. The approval came after CEO Elon Musk made a... Read More
India, April 29 -- The U.S. dollar rebounded against some of major counterparts in the New York session on Monday. The greenback recovered to 0.6546 against the aussie and 0.5959 against the kiwi, fr... Read More
India, April 29 -- Stocks are seeing modest strength during trading on Monday, adding to the substantial gains posted last week. The major averages have all moved to the upside on the day, although bu... Read More
India, April 29 -- Genuine Parts Co. (GPC) said that Paul Donahue will transition from chairman and chief executive officer to executive chairman, effective June 3, 2024. At that time, William Stengel... Read More
India, April 29 -- A study led by NASA researchers provides new estimates of the world's river water storage and discharge levels. Data on how much water courses through Earth's rivers, the rates at ... Read More
India, April 29 -- The U.S. Food and Drug Administration approved the supplemental Biologics License Application or sBLA granting full approval for TIVDAK (tisotumab vedotin-tftv) for the treatment of... Read More